You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low or intermediate-1 risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

Not yet recruiting
  • MDS
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2021

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)

Completed
  • Prostate Cancer
  • HDR brachytherapy as monotherapy
  • Greenfield Park, Quebec, Canada
    Hôpital Charles LeMoyne
Mar 15, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)

Recruiting
  • Prostate Cancer
  • Low dose rate prostate brachytherapy
  • High Dose Rate prostate brachytherapy
  • Kelowna, British Columbia, Canada
    British Columbia Cancer Agency Center for the Southern Interior
Mar 3, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)

Recruiting
  • Prostate Cancer
  • Soractelite Echolaser Transperineal focal laser ablation
  • Roma, RM, Italy
    San Carlo di Nancy Hospital
Oct 16, 2022

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)

Recruiting
  • Breast Cancer
  • external beams radiotherapy
  • brachytherapy
  • Rozzano, Milano, Italy
    IRCCS Istituto Clinico Humanitas
Jan 13, 2023

Prostate Cancer Trial in Chapel Hill (68Ga-HBED-CC-PSMA)

Recruiting
  • Prostate Cancer
  • Chapel Hill, North Carolina
    University of North Carolina - Chapel Hill
Jan 31, 2023

Low or Intermediate Risk Prostate Cancer Trial in Toronto (Advanced imaging for radiotherapy planning and guidance)

Active, not recruiting
  • Low or Intermediate Risk Prostate Cancer
  • Advanced imaging for radiotherapy planning and guidance
  • Toronto, Ontario, Canada
    University Health Network
Oct 21, 2022

Pulmonary Embolism Trial in Bispebjerg, Copenhagen, Herlev (Alteplase 20 Mg Powder for Solution for Injection Vial, Ultrasound

Recruiting
  • Pulmonary Embolism
  • Alteplase 20 Mg Powder for Solution for Injection Vial
  • Ultrasound assisted Thrombolysis
  • Bispebjerg, Denmark
  • +2 more
Oct 25, 2022

Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • Radiotherapy - Low risk group
  • +3 more
  • (no location specified)
Sep 18, 2023

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

Low/Intermediate Risk-1 MDS Trial in Beijing (Danazol + rhTPO (recombinant human thrombopoietin injection), Danazol + sodium

Active, not recruiting
  • Low/Intermediate Risk-1 MDS
  • Danazol + rhTPO (recombinant human thrombopoietin injection)
  • Danazol + sodium chloride
  • Beijing, China
    Peking union medical college hospital
Mar 26, 2020

Anemia Trial in Dresden (ACE-536)

Completed
  • Anemia
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

MDS Trial in Dresden (ACE-536)

Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
    Acceleron Investigative Site
Apr 29, 2021

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)

Recruiting
  • Prostate Cancer
  • Robotic hemi-prostatectomy with urethral preservation
  • Candiolo, TO, Italy
    Fondazione del Piemonte per l'Oncologia
Apr 16, 2023

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary

Recruiting
  • Pulmonary Embolism
  • Tissue Plasminogen Activator, Alteplase
  • Low-molecular weight heparin
  • İzmir, Bornova/İzmir, Turkey
    Ege University
Aug 22, 2022